Allarity Therapeutics Competitors and Similar CompaniesClear all
Allarity Therapeutics's competitors and similar companies include Esperance Pharmaceuticals, Apollomics, Gradalis and ImmuneSensor Therapeutics.
 Allarity Therapeutics Allarity Therapeutics (formerly known as Oncology Venture) is a drug development company dedicated to unlocking the potential of oncology products and rescue failed drugs. |  Esperance Pharmaceuticals Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs. |  Apollomics Apollomics (formerly known as CBT Pharmaceuticals) is a biopharmaceutical company committed to developing medicines targeting the growth and proliferation of cancer cells. |  Gradalis Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer. |  ImmuneSensor Therapeutics ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases. | |
Founding Date | Founding Date 2004 | Founding Date 2006 | Founding Date 2015 | Founding Date 2003 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ Hørsholm, DK | Locations Houston, US HQ | Locations Foster City, US HQ Southbank, AU Hangzhou, CN Shanghai, CN | Locations Carrollton, US HQ | Locations Dallas, US HQ |
Employees | Employees 5 | Employees 8 | Employees 1371% decrease | Employees 25 | Employees 11 |
Valuation ($) | Valuation ($) 2.2 m | Valuation ($) N/A | Valuation ($) 14.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (kr47.7m) (FY, 2020) | Net income N/A | Net income ($10.9m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 7.5m (almost 15 years ago) | Latest funding round N/A | Latest funding round $ 43.9m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 929.1k | Total funding raised $ 28.7m | Total funding raised $ 238.8m | Total funding raised $ 67.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Esperance Pharmaceuticals
HQ
Houston, US
Employees
8
Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs.
View companyApollomics
HQ
Foster City, US
Employees
13
Apollomics (formerly known as CBT Pharmaceuticals) is a biopharmaceutical company committed to developing medicines targeting the growth and proliferation of cancer cells.
View companyGradalis
HQ
Carrollton, US
Employees
25
Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer.
View companyImmuneSensor Therapeutics
HQ
Dallas, US
Employees
11
ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases.
View company